FDA Inspection
CGG Medical IncCGG Medical Inc – FDA Inspection, Feb 11, 2019
Record Details
This FDA Inspection record concerns CGG Medical Inc, with an inspection on February 11, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 8a722d79-204a-466e-b94d-13dc07e4071e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1078933
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.180(a)Procedures to meet core CTGP
- 21 CFR 1271.320(a)Procedures re complaints
Full citation text and observation details available on the Dashboard.
Other FDA inspections of CGG Medical Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 24, 2025 | Not classified | Florida District Office | |
| July 21, 2021 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for CGG Medical Inc
- FDA Inspection 1269682 - 2025-04-24
- FDA Inspection 1147263 - 2021-07-21
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.